Efficacy evaluation of Shengmai Injection in treating coronary heart disease based on random walk model

Journal of Chinese Integrative Medicine

Volumn 6, Issue 9, 2008, Pages 902-906

  Gao, Zhu Ye ^a   Xu, Hao ^b   Chen, Ke Ji ^a,b   Shi, Da Zhuo ^a   Li, Li Zhi ^a   Zhou, Xue Zhong ^c  

^a XIYUAN HOSPITAL   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c BEIJING JIAOTONG UNIVERSITY   (China)

Author keywords

Coronary disease; Random walk model; Shengmai Injection; Treatment effectiveness

Indexed keywords

CHINESE DRUG; SHENGMAI; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFICACY; FATALITY; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MEDICAL RECORD; MORTALITY; PATIENT INFORMATION; SCORING SYSTEM; SYMPTOM; THEORETICAL MODEL; THERAPY EFFECT;

AGED; CORONARY DISEASE; DIAGNOSIS, DIFFERENTIAL; DRUG COMBINATIONS; DRUG EVALUATION; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; MODELS, THEORETICAL;

EID: 52949121765     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20080905     Document Type: Article

References (12)

1. Wu DC, Liao Q. Random walk terminally attached to wall on different lattices. Ke Xue Tong Bao. 1997; 42 (1): 102-105.
2. Suchard MA. Stochastic models for horizontal gene transfer: taking a random walk through tree space. Genetics. 2005; 170(1): 419-431.
3. Paul RK, Rosenberger WF, Flournoy N. Quantile estimation following non-parametric phase I clinical trials with ordinal response. Stat Med. 2004; 23(16): 2483-2495.
4. Peng CK, Buldyrev SV, Goldberger AL, et al. Long-range correlations in nucleotide sequence. Nature. 1992; 356(6365): 168-170.
5. Society of Cardiology, Chinese Medical Association. Guidelines for the diagnosis and treatment of patients with acute myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi. 2001; 29(12): 710-725.
6. Bureau of Drug Administration of China Ministry of Public Health. Guidelines of clinical research on Chinese new herbal medicines. Beijing: Chinese Medical Science and Technology Press. 2002: 56-75.
7. Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995; 25 (2): 333-341.
8. Spertus JA, Winder JA, Dewhurst TA, et al. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol. 1994; 74(12): 1240-1244.
9. Shi DZ, Xu LL, Xu H. Study on traditional Chinese medicine for prevention and treatment of acute myocardial infarction after reconstruction of blood circulation. Zhong Yi Za Zhi. 2003; 44(7): 488-490.
10. Wang SY, Cao SM, Peng G, et al. Curative effect of cyclic adenosine monophosphate and Shengmai Injection on the aged patients with sinus bradycardia. Zhong Xi Yi Jie He Xue Bao. 2003; 1(1): 23-24.
11. Plank MJ, Sleeman BD. A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies. Math Med Bid. 2003; 20(2): 135-181.
12. Xiong X, Tan M, Boyett JM. A sequential procedure for monitoring clinical trials against historical controls. Stat Med. 2007; 26(7): 1497-1511.